Mar 08, 2022 / 05:50PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Well, good afternoon, and welcome to the AbbVie session of Cowen's 42nd Annual Healthcare Conference. We're very, very pleased to have the company back with us again this year.
Representing the company are 3 members of senior management: Mike Severino, who is Vice Chairman and President; Rob Michael, who is Vice Chairman, Finance and Commercial Operations and Chief Financial Officer; and Jeff Stewart, who is the Executive Vice President and Chief Commercial Officer.
There's always lots of ground to cover with AbbVie given a multitude of growth drivers, which seem to be delivering simultaneously. So let's dig right in, and I'll start it out with a look into the future.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystSo we're all obviously aware of the Humira patent expiration that's upcoming. But thereafter, it looks like a pretty vibrant second half to the decade
Trustpilot
